GlassScriptPhysician profile
Christopher T Tikum
NPI 1578269056
$5,044.22
in general payments reported to CMS, 2019-2025
16 companies · $2,955 in 2025
The $2,955 reported for 2025 was more than what 96% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $590 · 2024: $1,500 · 2025: $2,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,033 · Education: $11.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,033.07 |
| Education | $11.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,313.85 | 2023-2025 | Aristada, Lybalvi, Aristada Initio |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,056.86 | 2023-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $725.72 | 2023-2025 | Ingrezza |
| Abbvie INC. | $538.51 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $461.14 | 2023-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $217.86 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $176.98 | 2024-2025 | Rexulti, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $162.37 | 2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $155.39 | 2024-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Vanda Pharmaceuticals INC. | $75.92 | 2023-2025 | Hetlioz, Fanapt |
| Supernus Pharmaceuticals, INC. | $48.80 | 2024 | Qelbree |
| Axsome Therapeutics, INC. | $31.80 | 2025 | Auvelity |
| Inari Medical, INC. | $26.17 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bausch Health US, LLC | $18.90 | 2025 | Wellbutrin |
| Merck Sharp & Dohme LLC | $17.00 | 2023 | Belsomra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $16.95 | 2023 | Perseris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tikum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.